Spore.Bio is a privately held company tracked for investment-relevant business and technology developments.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Spore.Bio's TMSI technology combines photonics and a foundation model trained on millions of microbial events to detect, quantify, and identify bacteria in 10 minutes versus 2-14 days for traditional Petri dish methods, targeting a $50B microbiology market and multi-trillion dollar long-term opportunity across clinical, food, pharma, and environmental applications.